Investments
41Portfolio Exits
8Funds
1Latest Marshall Wace Asset Management News
Nov 27, 2023
November 27, 2023 at 10:22 am EST Share (Alliance News) - The following net short positions are the latest provided by Consob and updated as of Nov. 24, 2023: ---------- ---------- ---------- ---------- ---------- ---------- ---------- Comments and questions to redazione@alliancenews.com Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved. Share Legal disclaimer Back Add to a list Saipem S.p.A. specializes in engineering and construction services for the oil and gas industries. Net sales break down by activity as follows: - engineering, construction and installation services (94%): offshore services (submarine pipelines, oil platforms, etc.) and onshore (pipelines in hostile environments, hydrocarbon production units, drilling installations, refineries, etc. ), and construction of floaters; - offshore drilling services (6%). Net sales are distributed geographically as follows: Italy (4.4%), Europe (11.3%), Middle East (29%), Sub-Saharan Africa (26.5%), Far East (11.6%), Americas (8.8%), CIS (7%) and North Africa (1.4%). Sector
Marshall Wace Asset Management Investments
41 Investments
Marshall Wace Asset Management has made 41 investments. Their latest investment was in SAB Biotherapeutics as part of their PIPE on October 10, 2023.
Marshall Wace Asset Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/5/2023 | PIPE | SAB Biotherapeutics | Yes | 2 | ||
9/7/2023 | Seed VC | BlueWhale Bio | $18M | Yes | Danaher Ventures, Hillhouse Capital Management, Novalis LifeSciences, and Undisclosed Investors | 2 |
8/30/2023 | Series D | Beta Bionics | $100M | Yes | 5 | |
8/9/2023 | Series C | |||||
8/7/2023 | PIPE - II |
Date | 10/5/2023 | 9/7/2023 | 8/30/2023 | 8/9/2023 | 8/7/2023 |
|---|---|---|---|---|---|
Round | PIPE | Seed VC | Series D | Series C | PIPE - II |
Company | SAB Biotherapeutics | BlueWhale Bio | Beta Bionics | ||
Amount | $18M | $100M | |||
New? | Yes | Yes | Yes | ||
Co-Investors | Danaher Ventures, Hillhouse Capital Management, Novalis LifeSciences, and Undisclosed Investors | ||||
Sources | 2 | 2 | 5 |
Marshall Wace Asset Management Portfolio Exits
8 Portfolio Exits
Marshall Wace Asset Management has 8 portfolio exits. Their latest portfolio exit was Forge Biologics on November 13, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/13/2023 | Acquired | 4 | |||
Date | 11/13/2023 | ||||
|---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 4 |
Marshall Wace Asset Management Fund History
1 Fund History
Marshall Wace Asset Management has 1 fund, including Eureka Strategic Partners.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/31/2000 | Eureka Strategic Partners | UNKNOWN | Closed | $135.36M | 1 |
Closing Date | 12/31/2000 |
|---|---|
Fund | Eureka Strategic Partners |
Fund Type | UNKNOWN |
Status | Closed |
Amount | $135.36M |
Sources | 1 |
Marshall Wace Asset Management Team
5 Team Members
Marshall Wace Asset Management has 5 team members, including current Chief Executive Officer, Amit Rajpal.
Name | Work History | Title | Status |
|---|---|---|---|
Amit Rajpal | Morgan Stanley, and Prime Securities | Chief Executive Officer | Current |
Name | Amit Rajpal | ||||
|---|---|---|---|---|---|
Work History | Morgan Stanley, and Prime Securities | ||||
Title | Chief Executive Officer | ||||
Status | Current |
Loading...